Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Pfizer
(NY:
PFE
)
29.83
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Sep 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Pfizer
< Previous
1
2
...
27
28
29
30
31
32
33
34
35
...
99
100
Next >
As 2023 Comes To A Close And Updates Are Expected From Many Companies, Are These Three Unique Biotech Names On Your Watchlist?
December 18, 2023
Biotech stocks have had a tough run in 2023 so far. As of early November, the iShares Biotechnology ETF (IBB) was down 7.5% while the S&P 500 was up more than 14%.
Via
Benzinga
Topics
ETFs
2 High-Yield Dividend Stocks That Could Climb 29% and 24% in 2024, According to Wall Street.
December 18, 2023
These dividend payers offer attention-getting yields and a chance for significant growth of your principal investment.
Via
The Motley Fool
3 Stocks Down 30% or More This Year That Wall Street Expects to Skyrocket in 2024
December 18, 2023
Analysts think these beaten-down stocks could rebound strongly in the new year.
Via
The Motley Fool
3 of the Most Attractive Dividend Stocks in the Pharma Space
December 17, 2023
Discover the resilience and growth potential of pharma dividend stocks, offering stability and consistency in the healthcare sphere.
Via
InvestorPlace
7 Undervalued Biotech Stocks That are Flying Under the Clinical Radar
December 17, 2023
While the broader healthcare sector offers myriad opportunities, these undervalued biotech picks could offer robust upside.
Via
InvestorPlace
Should You Worry About the Latest Wave of Bad News from Pfizer?
December 17, 2023
In response to the news, Pfizer shares fell to a 10-year low.
Via
The Motley Fool
Could Pfizer Stock Help You Become a Millionaire?
December 16, 2023
Everyone has been talking about this stock, but that alone doesn't make it a good buy.
Via
The Motley Fool
Pfizer Dividend Increase
December 15, 2023
Pfizer announced its next dividend of $0.42 per share, a 2.44% increase over the company's previous payout of $0.41.
Via
Talk Markets
3 S&P 500 Stocks That Are About to Get Absolutely Crushed
December 16, 2023
Investors should be careful with these securities, each of which has been slumping and could fall further in the year ahead.
Via
InvestorPlace
Topics
Stocks
Exposures
US Equities
3 Fantastic Stocks That Could Enjoy a Santa Claus Rally
December 16, 2023
These stocks could bring investors more than just a lump of coal for Christmas.
Via
The Motley Fool
Exposures
Coal
What's Going On With Pfizer Stock?
December 15, 2023
Pfizer, Inc. (NYSE: PFE) shares are trading higher Friday. The stock remains down by more than 11% over the past five days and down by more than 47% year-to-date.
Via
Benzinga
Stock Market Rally Surges To 2023 Highs As Fed Pivots Toward Rate Cuts: Weekly Review
December 15, 2023
The Dow hit a record high while the S&P 500 and Nasdaq set 2023 bests.
Via
Investor's Business Daily
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
The Pain Continues For Bedraggled Pharma Heavyweight Pfizer
December 15, 2023
Yet another analyst cut expectations and his price target on Pfizer stock Friday.
Via
Investor's Business Daily
Why the dividend investor may take a look at NYSE:PFE.
December 15, 2023
Is PFIZER INC (NYSE:PFE) suited for dividend investing?
Via
Chartmill
What's Going On With BioNTech (BNTX) Shares?
December 13, 2023
BioNTech SE - ADR (NASDAQ: BNTX) shares are trading lower by 5.6% to $93.10 Wednesday afternoon.
Via
Benzinga
3 No-Brainer Healthcare Stocks to Buy Right Now
December 15, 2023
These players have what it takes to boost your portfolio over time.
Via
The Motley Fool
Costco, Pfizer, Moderna, Lennar Corp, Tesla: Why These 5 Stocks Are On Investors' Radars Today
December 14, 2023
The stock market witnessed a notable surge today, with the Dow Jones rising 0.43% to 37,248.35 and the S&P 500 gaining 0.26% to 4,719.55.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
SpaceX Worth $180 Billion Now: Musk-Owned Company's Value Tops Boeing, Lockheed Martin, Disney, Verizon, IBM, Pfizer, UPS
December 14, 2023
A new funding round for SpaceX values the private space company at a reported $180 billion. A look at how that compares to public companies.
Via
Benzinga
MRNA Stock Surges as Moderna Teams Up With Merck to Fight Cancer
December 14, 2023
Moderna is in focus after reporting positive results for its cancer treatment today, with MRNA stock surging more than 9%.
Via
InvestorPlace
3 Stocks That Are About to Get Absolutely Crushed
December 14, 2023
These are a few different companies that are experiencing difficult times and that are expected to keep falling.
Via
InvestorPlace
Moderna CEO Highlights Promising Cancer Vaccine Data: 'Think About The Number Of Lives That Can Be Impacted'
December 14, 2023
Moderna, Inc. (NASDAQ: MRNA) CEO Stéphane Bancel appeared on CNBC's "Squawk Box" Thursday to discuss the company's promising new cancer vaccine developed in
Via
Benzinga
Pfizer's 2030 Vision Bolstered By Seagen Deal, Analyst Cuts Price Target Amid Conservative 2024 Forecast
December 14, 2023
Truist Securities analyst Robyn Karnauskas reiterated a Buy rating on Pfizer, Inc. (NYSE: PFE),
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
December 14, 2023
Via
Benzinga
The Vaccine Group appoints advisory board in partnering push
December 14, 2023
--News Direct--
Via
News Direct
Are These 3 Cheap Dividend Stocks With High Yields Too Good to Be True?
December 14, 2023
The highest-yielding stock on this list pays 7.7%.
Via
The Motley Fool
Harmonic To Rally Over 80%? Here Are 10 Top Analyst Forecasts For Thursday
December 14, 2023
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via
Benzinga
Moderna's Cancer Vaccine Cuts Risk Of Relapse, Death By 49%; Will Shares Jump?
December 14, 2023
Moderna and Merck are already working on a Phase 3 study, but these are long-running tests.
Via
Investor's Business Daily
Pfizer's 2024 Outlook Disappointed Wall Street, But Where Will the Stock Be in 5 Years?
December 14, 2023
Pfizer recently outlined expectations for 2024 results in light of an upcoming $43 billion acquisition of Seagen.
Via
The Motley Fool
Apple, Adobe, Pfizer, Alibaba, Tesla: Why These 5 Stocks Are On Investors' Radars Today
December 13, 2023
Via
Benzinga
Why Despegar.com Shares Are Trading Higher By Over 16%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
December 13, 2023
Shares of Despegar.com, Corp. (NYSE: DESP) rose sharply during Wednesday’s session after the company raised its FY23 financial guidance. The company said it now sees revenue of $690 million to $700...
Via
Benzinga
< Previous
1
2
...
27
28
29
30
31
32
33
34
35
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.